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Objective A substantial part of non-traumatic intracerebral haemorrhages (ICH) arises from a 
macrovascular cause, but there is little guidance on selection of patients for additional diagnostic 
work-up. We aimed to develop and externally validate a model for predicting the probability of a 
macrovascular cause in patients with non-traumatic ICH. 
Methods The DIAGRAM study (N=298; 69 macrovascular cause; 23%) is a prospective, 
multicentre study, assessing yield and accuracy of CTA, MRI/MRA and intra-arterial catheter 
angiography in diagnosing macrovascular causes in patients with non-traumatic ICH. We 
considered pre-specified patient and ICH characteristics in multivariable logistic regression 
analyses as predictors for a macrovascular cause. We combined independent predictors in a 
model, which we validated in an external cohort of 173 ICH patients (78 macrovascular cause, 
45%).  
Results Independent predictors were younger age, lobar or posterior fossa (versus deep) location 
of ICH and absence of small vessel disease (SVD). A model that combined these predictors 
showed good performance in the development data (c-statistic 0.83; 95% CI 0.78-0.88) and 
moderate performance in external validation (c-statistic 0.66; 0.58-0.74). When CTA results 
were added, the c-statistic was excellent (0.91; 0.88-0.94), and good after external validation 
(0.88; 0.83-0.94). Predicted probabilities varied from 1% in patients aged 51-70 years with deep 
ICH and SVD, to more than 50% in patients aged 18-50 years with lobar or posterior fossa ICH 
without SVD.   
Conclusion The DIAGRAM scores help to predict the probability of a macrovascular cause in 





Intracerebral haemorrhage (ICH) accounts for 15-20% of all strokes and is the most devastating 
stroke subtype.[1,2] Around 15-25% of ICHs are caused by an underlying macrovascular cause, 
such as an arteriovenous malformation (AVM), aneurysm, dural arteriovenous fistula (dAVF), 
cavernoma, and cerebral venous sinus thrombosis.[3-5] Among young adults, macrovascular 
causes are the leading cause of ICH.[6]  
Early diagnosis of underlying macrovascular lesions can influence clinical management and 
prognosis, as timely intervention might prevent recurrent haemorrhage.[7,8] Intra-arterial digital 
subtraction angiography (IADSA) is the gold standard for detection of macrovascular 
abnormalities, but is an invasive procedure associated with some risk of complications.[9] 
MRI/MRA is less invasive, but has lower diagnostic accuracy for macrovascular causes than 
IADSA.  
Currently, there is little guidance on which patients to select for (invasive) angiographic imaging 
and clinical practice thus varies widely.[10] Several factors have been associated with a higher 
likelihood of finding a macrovascular cause, including younger age, lobar location and absence 
of hypertension.[11] Early risk stratification of patients with ICH might help physicians to make 
swift, well-informed decisions about who to select for further angiographic imaging.  
We aimed to develop and externally validate a prediction model to estimate the probability of 
finding a macrovascular cause in patients with non-traumatic ICH, based on patient 






We used data from the DIagnostic AngioGRAphy to find vascular Malformations (DIAGRAM) 
study, a prospective, multicentre cohort study that assessed yield and diagnostic accuracy of 
angiographic imaging (CTA, MRA, IADSA) in patients with non-traumatic ICH.[12] Between 
2008 and 2014, 298 patients aged 18-70 years were included in 22 participating centres across 
the Netherlands. Patients over 45 years of age with hypertension and ICH in the basal ganglia, 
thalamus or posterior fossa were excluded, because of the low probability of finding an 
underlying macrovascular cause.[13] Also, patients with a known macrovascular abnormality, 
brain tumour or patients who used oral anticoagulants and had an INR of >2.5 at the time of ICH 
were excluded. All patients underwent CTA within seven days of the ICH, followed by 
MRI/MRA within four to eight weeks if the CTA was negative. Patients underwent subsequent 
IADSA if the results of CTA or MRI/MRA were inconclusive or negative. CTA or MRI/MRA 
were considered inconclusive if a macrovascular cause was suspected but a definite diagnosis 
could not yet be established. Scans were read both locally and centrally. In case of a new 
diagnosis, local centres were informed. One additional arteriovenous fistula was detected at 
central reading. 
Two hundred ninety-one patients had a CTA of sufficient quality for assessment (98%). 
MRI/MRA was performed in 255 patients (86%), of whom 214 patients with a negative or 
inconclusive CTA and IADSA in 154 patients (52%), of whom 106 patients with a negative or 
inconclusive CTA (Supplemental Figure I). Quality of IADSA was insufficient for assessment in 
three patients. One hundred twenty-six patients had a negative or inconclusive CTA, but did not 
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undergo subsequent IADSA. The main reason for not performing IADSA in patients with a 
negative CTA was an alternative diagnosis on MRI/MRA, or reluctance of either patients or their 
treating physicians. Four patients with a negative CTA died before MRI/MRA could be 
performed. The outcome was presence of a macrovascular cause (AVM, aneurysm, dAVF, 
cavernoma, cerebral venous sinus thrombosis and developmental venous anomaly (DVA)) as 
cause of the haemorrhage, and was based on best available evidence from all findings (CTA, 
MRA, DSA) during one year follow-up. The DIAGRAM study was approved by the medical 
ethics committee of the University Medical Center Utrecht, the Netherlands, and local approval 
was obtained from all participating hospitals. All participants gave written informed consent. 
Model development 
Candidate predictors were pre-selected based on the literature and included age, hypertension 
(defined as a history of hypertension, use of antihypertensive drugs before ICH or evidence of 
left ventricular hypertrophy on admission ECG), smoking, high alcohol intake (defined as four or 
more units per day), location of ICH (lobar, deep or posterior fossa), presence of small vessel 
disease (SVD) on non-contrast CT (NCCT) (defined as presence of white matter lesions, or a 
lacunar infarct in basal ganglia, thalamus or posterior fossa, irrespective of whether it had been 
symptomatic or was an asymptomatic finding  (see Supplemental Methods for a detailed 
description of SVD assessment and Supplemental Figure II)) and CTA. We developed two 
models; one model based on patient characteristics and NCCT (DIAGRAM score) and another 
model based on patient characteristics, NCCT and results from CTA imaging for use in higher 
resource settings (DIAGRAM+ score), which may help to estimate the probability of a 
macrovascular cause given that CTA is negative. For the current analysis, inconclusive CTAs 
were joined with positive results, because a CTA suggesting a macrovascular cause, yet 
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inconclusive, will always trigger further diagnostic tests. Given the one in ten rule with one 
predictive variable for every ten outcome events, we could study a maximum of seven 
predictors.[14,15]  
Statistical Analysis 
Missing values for alcohol consumption (1%), smoking (1%) and CTA (2%) in the development 
cohort were imputed with single imputation. We used restricted cubic spline functions and 
graphs to assess whether age could be analysed as linear term or needed transformation. We 
performed multivariable logistic regression analysis to study the association between candidate 
predictors and the presence of a macrovascular cause. The full model containing all candidate 
predictors was simplified by performing backward selection based on Akaike’s Information 
Criterion (AIC). We internally validated the model by performing bootstrapping. A shrinkage 
factor was estimated from the bootstrap procedure and regression coefficients were multiplied by 
this shrinkage factor to correct for overfitting. Model performance was assessed with 
discrimination and calibration. Discrimination refers to the ability of the model to distinguish 
between someone with and without a macrovascular cause and was assessed with the c-statistic. 
Calibration assesses the correspondence between observed and predicted risk and was studied 
with a calibration plot. As a sensitivity analysis, we examined the performance of the models in a 
subset of patients (n=171), excluding those who did not undergo IADSA following a negative or 
inconclusive CTA. We generated prediction charts with predicted probabilities of finding a 
macrovascular abnormality for each combination of risk factors. Additionally, we created two 
prediction scores based on regression coefficients of the final multivariable regression models. 





For external validation, we used a cohort of 173 patients with non-traumatic ICH.[16] 
Consecutive patients who underwent IADSA at the National Hospital for Neurology and 
Neurosurgery in London between 2010 and 2014 were retrospectively reviewed. Patients with 
non-traumatic ICH with available NCCT and CTA were included. NCCT and CTA were 
routinely performed in all patients with acute ICH presenting to the hyperacute stroke unit, 
unless there were contra-indications. The necessity of IADSA performance was judged in a 
weekly neuroradiological meeting, and was based on age, ICH location and medical history. 
MRI was performed according to clinical care, but was not systematically undertaken in all 
patients. The reference standard in the validation cohort was IADSA. All CTAs were reviewed 
blinded to IADSA result. The study was approved by the Clinical Governance Committee of the 
National Hospital and the UCL Institute of Neurology and National Hospital Joint Research 
Ethics Committee.  
We applied the original regression equation to the validation data and calculated the predicted 
probability of finding a macrovascular cause for each patient. We assessed model performance 
with the c-statistic and calibration plots. As calibration is known to be strongly influenced by the 
incidence of the outcome in the validation population, we recalibrated the prediction models. 
Recalibration was performed by logistic regression analysis in the validation data with the linear 
predictor (the combination of regression coefficients with covariate values) as offset in the 
model. The resulting intercept was combined with the original regression coefficients to obtain 
predicted probabilities for the validation population. We present calibration of the models after 
recalibration, as in practice it is also advised to recalibrate a model before putting it to use. 
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Calibration results before recalibration are provided in the online supplement. Analyses were 
performed with R version 3.3.2. Results are reported in accordance with the TRIPOD 




Table 1 shows the baseline characteristics of the development and validation cohorts.  
Table 1. Baseline characteristics of development and external validation cohort 













Age, mean (SD), 
years 
47 (12.7) 55 (10.5) 49 (17) 50 (13) 
Male sex 45 (65) 140 (61) 39 (50)  54 (57) 
Smoking (current) 20 (29) 52 (23) - - 
High alcohol 
intake 
4 (6) 32 (14) - - 
Hypertension 16 (23) 79 (35) 16 (21) 37 (39) 
Location of ICH     
   Deep 5 (7) 80 (35) 14 (18) 46 (48) 
   Lobar 49 (71) 129 (56) 46 (59) 37 (39) 
   Posterior fossa 15 (22) 20 (9) 13 (17) 15 (16) 
   IVH - - 6 (8) 3 (3) 
Signs of small 
vessel disease 
4 (6) 116 (51) 12 (15) 35 (37) 
CTA     
   Positive 47 (68) 12 (5) 53 (68) 0 (0) 
   Inconclusive 4 (6) 8 (4) 11 (14) 7 (7) 
Values are numbers (percentage), unless otherwise stated. ICH, intracerebral haemorrhage; IVH, 
intraventricular haemorrhage; SVD, small vessel disease; CTA, computed tomography 
angiography 
 
Among 298 patients included in the development cohort, 69 (23%) had an underlying 
macrovascular cause (for listing of all causes, see Supplemental Table I). In the validation cohort 
a macrovascular cause was found in 78 of 173 patients (45%). Patients in the development cohort 
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were slightly older (mean age 53 years, SD 11.5 versus 50 years, SD 15.0 in the validation 
cohort). The frequency of underlying vascular aetiologies in each cohort is presented in Table 2.  








ICH, intracerebral haemorrhage; * this patient had a large developmental venous anomaly with 
partial thrombosis, which was clearly the cause of the ICH.   
 
In multivariable analysis younger age, location of ICH, absence of signs of SVD and a positive 
or inconclusive CTA were independent predictors for presence of an underlying macrovascular 
cause (Table 3).  
Table 3. Odds ratios for presence of a macrovascular cause from multivariable models in 
the development cohort  
 Patient characteristics  
and NCCT 
OR (95% CI) 
Patient characteristics,  
NCCT and CTA 
OR (95% CI) 
Age 0.95 (0.93-0.98) 0.97 (0.94-1.00) 
Location   
   Deep  1 [Ref] 1 [Ref] 
   Lobar 7.2 (2.8-22.4) 4.0 (1.3-14.2) 
   Posterior fossa 19.3 (5.8-75.4) 9.9 (2.5-44.9) 
Absence of SVD 11.8 (4.4-41.2) 11.8 (3.7-48.6) 
Positive or inconclusive CTA - 15.9 (7.5-35.5) 




Arteriovenous malformation 34 (49) 68 (87) 
Dural arteriovenous fistula 13 (19) 7 (9) 
Cavernoma 10 (14) - 
Cerebral venous sinus thrombosis 4 (6) - 
Aneurysm 7 (10) 2 (3) 
Developmental venous anomaly* 1 (1) - 
Carotid cavernous fistula - 1 (1) 
Total 69 78 
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NCCT: non-contrast CT, CTA: computed tomography angiography, SVD: small vessel disease, 
CI: confidence interval, OR: odds ratio, [Ref]: reference 
 
A simple model based on age, location of ICH and signs of SVD had a c-statistic of 0.83 (95% 
CI 0.78 to 0.88) in the development cohort after shrinkage. The predictive performance of the 
model increased if CTA was included as predictor (c-statistic 0.91; 95% CI 0.88 to 0.94). 
Calibration of both models was accurate, as shown by the calibration plots (Figure 1). The 
original regression equations are provided in Supplemental Table II. When we excluded patients 
in whom IADSA was not performed following a negative or inconclusive CTA, c-statistics were 
similar to those of the full cohort analysis. Calibration plots and c-statistics are presented in 
Supplemental Figure III. 
Figure 2 shows risk charts with estimated probabilities of finding a macrovascular cause 
according to age, ICH location, presence of SVD, and for the same predictors combined with 
CTA. The probability of finding a macrovascular cause ranged from 1% in patients aged 51 to 70 
years with deep ICH and signs of SVD, up to more than 50% in patients aged 18 to 50 years with 
lobar or posterior fossa ICH and no signs of SVD. Two simple risk scores are presented in 
Supplemental Table III, which can be used in combination with Supplemental Figure IV to 
obtain predicted probabilities for individual patients. 
External validation 
External validation of the models showed a c-statistic of 0.66 (95% CI 0.58 to 0.74) for the 
model based on patient characteristics and NCCT, and a c-statistic of 0.88 (95% CI 0.83 to 0.94) 
for the model with additional CTA. The calibration plots show that the likelihood of finding a 
macrovascular cause increased along the range of predicted probabilities, with moderate 
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calibration for the model with patient characteristics and NCCT (Figure 1A) and good calibration 
for the model with additional CTA (Figure 1B). Before recalibration, both models systematically 





Our study shows that younger age, lobar or posterior fossa location of ICH, absence of signs of 
SVD, and a positive or inconclusive CTA are independent predictors for presence of a 
macrovascular cause in patients with non-traumatic ICH. We combined predictors in two 
practical prediction charts, which we externally validated. Estimated risks vary from 1% in 
patient aged 51 to 70 with deep ICH and signs of SVD, to more than 50% in patients aged 18 to 
50 with lobar or posterior fossa ICH and no signs of SVD. Both models showed good 
discriminatory ability and calibration in the development cohort, whereas performance in 
external validation was moderate for the model with NCCT and good for the model including 
CTA.  
Previously, two other prediction models have been described to predict the probability of a 
macrovascular cause in patients with non-traumatic ICH (Supplemental Table IV). The simple 
ICH score was developed in a retrospective cohort of 160 patients with non-traumatic ICH in 
which presence of a macrovascular cause was determined with IADSA.[18] Performance of the 
risk score was moderate in both the development and external validation cohort. This model was 
derived from a high-risk population, as represented by the relatively young age (mean age 41 
years) and high proportion of patients with a macrovascular cause (51%). The results may 
therefore not be generalizable to all patients with ICH suspected of having a vascular 
malformation, and the prediction model will likely overestimate the probability of finding a 
macrovascular cause. The secondary intracerebral haemorrhage score (SICH) was developed in a 
retrospective cohort of 623 patients with ICH in the US.[11] Presence of a macrovascular cause 
was determined with CTA. The model was based on patient characteristics and NCCT 
characteristics, which included enlarged vessels or calcifications along ICH margins and 
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hyperattenuation within a dural venous sinus or cortical vein. Independent validation in the US 
showed good performance of the model,[19] performance was moderate in an external validation 
study in the Netherlands.[3] NCCT categorization was a strong predictor for macrovascular 
causes, but characteristics were not always easy to recognize on NCCT,[3] which may limit easy 
application of the model in clinical practice. The DIAGRAM prediction score is the first model 
developed in a prospective cohort, excluding patients in whom yield of angiographic imaging has 
been shown to be very low (patients older than 45 years with a history of hypertension and a 
deep or posterior fossa bleed).[13] Next to known predictors for a vascular malformation, we 
were able to add signs of SVD as important predictor of absence of a macrovascular cause. To 
our knowledge, this is the first prediction model that also incorporated results from CTA 
imaging. This can be useful in healthcare settings where CTA is often or routinely used, and 
clinicians have to decide whether or not to perform MRI/MRA and/or IADSA after a negative 
CTA. The DIAGRAM prediction score may help to weigh the probability of finding a 
macrovascular cause against the risk of complications of IADSA.  
Performance of the model based on patient characteristics and NCCT diminished in the external 
validation cohort. This is likely due to differences between the development and validation 
cohorts in terms of patient selection and choice of reference standard. Selection of patients 
influences prevalence of macrovascular causes and may affect predictor outcome associations, 
which in turn affect model performance. By selection of patients who underwent IADSA in the 
validation cohort, the prior probability of finding a macrovascular abnormality in this cohort was 
higher, which resulted in a systematically underestimated risk of finding a macrovascular cause 
by the prediction models. Simple recalibration improved correspondence between observed and 
predicted risks, supporting the hypothesis that differences in outcome incidence were the main 
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source of miscalibration. Selection of more high-risk patients may also have altered predictor-
outcome associations. As a consequence, the discriminatory ability of the model may have 
decreased. Given differences between development and validation cohorts, validation of the 
DIAGRAM prediction model in a prospective cohort  is necessary to further establish the 
robustness of the model. 
Strengths of our study include the prospective nature of the development cohort and the 
standardized radiological work-up. Another strength is the external validation in a setting outside 
of the Dutch healthcare system. Our study also has limitations. First, the models were developed 
in a preselected group of patients with a relatively high likelihood of finding a macrovascular 
cause, excluding those older than 70 years of age, and patients over the age of 45 years with 
hypertension and deep ICH or ICH in the posterior fossa. This preselected group represents 
patients in whom the diagnostic dilemma is most pressing in clinical practice. Generalizability to 
older patients with non-traumatic ICH remains to be established. In the elderly, diagnostic tests 
to search for macrovascular causes of ICH are often performed in only a small proportion of 
patients.[20] Second, not all patients in the development cohort underwent IADSA. As a 
consequence, small AVMs or dAVFs may have been missed. However, patients were followed-
up for one year to assess occurrence of re-bleeds and register possible causes of ICH identified 
during follow-up. Third, the association between CTA and presence of a macrovascular cause 
may have been overestimated, as CTA was also part of the reference standard. However, when 
we restricted our analyses in the development cohort to the patients who underwent IADSA, the 
discriminatory performance of the model remained similar. Fourth, MRI/MRA was not 
systematically performed in the validation cohort, which may have led to underestimation of the 
number of patients in whom a cavernoma was the cause of ICH. 
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The current models may facilitate selection of patients for further diagnostic work-up. The 
results of the model based on patient characteristics and NCCT suggest that in the absence of 
SVD, some form of angiographic imaging (CTA/MRA/IADSA) should be performed in all 
patients under 70 years of age, regardless of ICH location. If signs of SVD are seen on NCCT, 
CTA should still be considered in young patients (18-50 years old) with lobar and posterior fossa 
ICH, and in elderly patients (51-70 years old) with posterior fossa ICH. In settings where it is 
feasible to perform CTA in all patients shortly after ICH, the DIAGRAM+ score is particularly 
useful in patients in whom CTA was negative to guide the decision to perform these additional 
tests. Following a negative CTA, there is still a substantial chance of finding a macrovascular 
cause in patients without signs of SVD, both in young and in older patients. In these patients, 
performance of MRI/MRA and IADSA deserves consideration, especially in patients with lobar 
and posterior fossa ICH. It should be noted that also in patients with a deep ICH who do not have 
SVD nor hypertension (as defined by the inclusion criteria), there is an around 9% (in those 18 to 
50 years) and 3% (in those 51 to 70 years) chance of finding a macrovascular cause of the ICH 
after a negative CTA. Whether or not in these patients further imaging will be performed should 
be determined as part of a shared decision making process between the patient and the team 
responsible for their care. Because the AVMs or dAVFs that are sought for with IADSA after a 
negative CTA will be small, IADSA should be performed in centres with ample experience in 
detecting such lesions. Although the prediction charts can provide guidance in decision-making, 
it should be noted that there is a degree of uncertainty around the presented estimates, as shown 
by the confidence intervals in Supplemental Figure IV.  
In conclusion, the DIAGRAM prediction charts can help to predict the probability of finding a 
macrovascular cause in both low and high resource settings. External validation of the models in 
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other prospective cohorts and in elderly patients is needed to gain further insight in the 
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Figure 1. Calibration plots of DIAGRAM prediction models in the development and 
validation cohort 
 
Figure legend: Model based on patient characteristics and NCCT (A), model based on patient 
characteristics, NCCT and CTA (B). The triangles indicate the observed frequencies with 95% 
confidence intervals by quintiles of predicted probability 
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Figure 2. Prediction charts with absolute probabilities (%) of an underlying macrovascular 
cause in individual patients with ICH 
 
Figure legend: ICH: intracerebral haemorrhage, NCCT: non contrast CT, SVD: small vessel 
disease, CTA: computed tomography angiography 
 
 
